Cargando…
Synergy between Non-Thermal Plasma with Radiation Therapy and Olaparib in a Panel of Breast Cancer Cell Lines
Cancer therapy has evolved to a more targeted approach and often involves drug combinations to achieve better response rates. Non-thermal plasma (NTP), a technology rapidly expanding its application in the medical field, is a near room temperature ionized gas capable of producing reactive species, a...
Autores principales: | Lafontaine, Julie, Boisvert, Jean-Sébastien, Glory, Audrey, Coulombe, Sylvain, Wong, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072235/ https://www.ncbi.nlm.nih.gov/pubmed/32033118 http://dx.doi.org/10.3390/cancers12020348 |
Ejemplares similares
-
Discovery of
Ruthenium(II) Metallocompound and Olaparib
Synergy for Cancer Combination Therapy
por: Yusoh, Nur Aininie, et al.
Publicado: (2023) -
Hypoxic Jumbo Spheroids On-A-Chip (HOnAChip): Insights into Treatment Efficacy
por: Refet-Mollof, Elena, et al.
Publicado: (2021) -
On-chip combined radiotherapy and chemotherapy testing on soft-tissue sarcoma spheroids to study cell death using flow cytometry and clonogenic assay
por: Patra, Bishnubrata, et al.
Publicado: (2019) -
Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells
por: Lafontaine, Julie, et al.
Publicado: (2021) -
PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation
por: Mao, Yize, et al.
Publicado: (2018)